T

wo major shareholder advisory firms are recommending that AmerisourceBergen (ABC) stockholders support a proposal to require the pharmaceutical wholesaler to report the steps being taken to manage financial and reputational risks associated with the opioid crisis.

The firms — Glass Lewis and Institutional Shareholder Services — also recommend shareholders back a proposal to disclose if its board claws back compensation from senior executives due to misconduct and another to split the chief executive and chairman jobs, a move that corporate governance experts often endorse as sound practice. The wholesaler holds its annual shareholder meeting on March 1.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy